During the past decade, Central Ohio Urology Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Ohio Urology Group" are "Castration-Resistant Prostate Cancer" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Central Ohio Urology Group" in a lesser frequency.

Most popular intervention types in "Central Ohio Urology Group" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic Implantable Tibial Neuromodulation (TNM) System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Ohio Urology Group" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central Ohio Urology Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Central Ohio Urology Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Ohio Urology Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".